Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

ClinicalTrials.gov ID: NCT00659373

Public ClinicalTrials.gov record NCT00659373. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Investigating Cognitive Function for Patients Participating in the SOFT Trial in Selected Centers

Study identification

NCT ID
NCT00659373
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ETOP IBCSG Partners Foundation
Network
Enrollment
86 participants

Conditions and interventions

Interventions

  • Tamoxifen Drug
  • triptorelin Drug
  • Exemestane Drug

Drug

Eligibility (public fields only)

Age range
Up to 120 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Nov 30, 2014
Completion
Mar 31, 2016
Last update posted
Jul 24, 2016

2007 – 2016

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Mercy General Hospital Sacramento California 95819
Front Range Cancer Specialists Fort Collins Colorado 80528
Norwalk Hospital Norwalk Connecticut 06856
Piedmont Hospital Atlanta Georgia 30309
Northside Hospital Cancer Center Atlanta Georgia 30342-1611
Saint Joseph's Hospital of Atlanta Atlanta Georgia 30342-1701
CCOP - Atlanta Regional Atlanta Georgia 30342
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care Concord New Hampshire 03301
Don Monti Comprehensive Cancer Center at North Shore University Hospital Manhasset New York 11030
Mission Hospitals - Memorial Campus Asheville North Carolina 28801
Batte Cancer Center at Northeast Medical Center Concord North Carolina 28025
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104-4283

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00659373, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2016 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00659373 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →